ReleaseWire Connect

Life Science Analytics’, Antidote Therapy Area Pipeline Report contains detailed information on the antidote drug pipeline. This report provides insight into the pipeline status of antidote drugs by company and by stage as well as a summary of the latest news and developments in this area.

Peer-to-peer lending has taken a small but growing share of gross advances in the UK unsecured personal lending market since the concept was born in 2005. It is now a viable alternative option for lenders and borrowers alike.

Children’s Publishing Market Forecast 2011 offers an accurate and objective perspective on where the market for children’s books is headed in 2011, as well as analysis of market.

The U.S. has the world’s largest mortgage market; in 2009 the country had an outstanding mortgage-to-GDP ratio - above 100%

Life Science Analytics’, Poisoning Therapy Area Pipeline Report contains detailed information on the poisoning drug pipeline. This report provides insight into the pipeline status of poisoning drugs by company and by stage as well as a summary of the latest news and developments in this area.

Life Science Analytics’, Abnormal Uterine Bleeding Therapy Area Pipeline Report contains detailed information on the abnormal uterine bleeding drug pipeline. This report provides insight into the pipeline status of abnormal uterine bleeding drugs by company and by stage as well as a summary of the latest news and developments in this area.

The Chinese hospital prescription pharma market generated sales of $22.9 billion in 2009, with an annual growth rate of 26.5% between 2008 and 2009. Key growth drivers include China’s support of foreign direct investment, low operating costs, growing economic wealth and a government stimulus of $125 billion to be spent on healthcare reforms during 2009–2011.

The antidyslipidemic market is expected to fall to $18 billion in 2018. The decline will be driven by the deep genericization of the market, further exacerbated by the patent expiry of the top antidyslipidemic, Pfizer's Lipitor, as well as by the recent negative messages from the ENHANCE, SEAS and ARBITER 6 HALTS clinical trials.

Life Science Analytics’, Smoking Cessation Therapy Area Pipeline Report contains detailed information on the smoking cessation drug pipeline. This report provides insight into the pipeline status of smoking cessation drugs by company and by stage as well as a summary of the latest news and developments in this area.

Life Science Analytics’, Opium Addiction Therapy Area Pipeline Report contains detailed information on the opium addiction drug pipeline. This report provides insight into the pipeline status of opium addiction drugs by company and by stage as well as a summary of the latest news and developments in this area.